Given that assay positivity corresponds to antibody levels of ≥ 1,400–1,800 U/ml when benchmarked against radioimmunoassay standards, all included patients meet the threshold for high-titre anti-GAD65 seropositivity associated with neurological disease [12, 13]. This evidence concerns the gene GAD2 and nervous system disorder.